Maple Fung Selected Research

lesinurad

1/2019	Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study.
12/2017	Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study.
5/2017	Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study).
1/2017	Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial.
1/2017	Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maple Fung Research Topics

Disease

8	Gout 01/2020 - 01/2017
1	Pain (Aches) 01/2019
1	Chronic Renal Insufficiency 05/2014

Drug/Important Bio-Agent (IBA)

7	Uric Acid (Urate)IBA 01/2020 - 01/2017
5	Allopurinol (Remid)FDA LinkGeneric 01/2020 - 01/2017
5	lesinuradIBA 01/2019 - 01/2017
2	Febuxostat FDA Link 01/2019 - 01/2017
2	Xanthine OxidaseIBA 12/2017 - 01/2017
1	2-(2,6-dioxopiperidin-3-yl)phthalimidine (EM 12)IBA 01/2019
1	Darbepoetin alfa (Aranesp)FDA Link 05/2014

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2017
1	Contraindications 12/2017